Health
Devices to beat hospital-acquired infections, prevent opioid overdoses and instantly spot infections in blood are among the pioneering healthcare innovations being showcased to family investors at the upcoming MedTech Investing Europe Conference in Lausanne.
How is one Chinese biotechnology group succeeding in supporting the earliest stage of new drug discovery when global pharmaceutical companies have given up? Dr Jun Mao, founder and chairwoman of Viva Ventures, explains how it leverages its in-house expertise to invest in hundreds of biotech startups in the $20 trillion global pharmaceutical and biotechnology market.
Merck had been able to continually anticipate changes in the macro-environment and adapt itself
A trio of international family business academics reveal how a modest German pharmacy has evolved into a successful 12-generation dynasty complete with its own family university
Feisal Alibhai, Qineticare founder and chief executive, reveals why a focus on the wellbeing of the family is the missing piece in the ability to achieve robust succession planning
The management of risk is essential to the human experience. For families who may be targets for attempted fraud, extortion or, in extreme cases, personal security risks such as kidnapping, mitigation begins with consciousness of the risks and having the right underlying protections in place.
Editor's Pick